Triple Hair Expands Global Phase III Program for TH07 with Launch of 500-Patient Trial in India
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.273 · RIGHT
Ensemble
0.137 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.045
2,788 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
Phase III trial in India expected to enroll 500 male patients with androgenic alopecia Study forms part of Triple Hair’s coordinated international Phase III program for TH07 Harmonized clinical design supports development of a robust global data package and enhances strategic relevance across major commercial markets MONTRÉAL — Triple Hair Group Inc. (“Triple Hair” or...
Read full article at Montreal Gazette ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
quick v1
Jun 8, 2026